Aller au contenu principal
Accès ouvert déclaré 2025 review

The Making of a cDC1 : Precision Programming of Progenitor Potential

3Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

The development of type 1 classical dendritic cells (cDC1s) from bone marrow progenitors is a multistage process directed by a complex transcriptional network. At its center is interferon regulatory factor-8 (IRF8), the lineage-determining factor whose precise, stage-specific expression is integrated at the Irf8 super-enhancer. This developmental sequence is initiated in early progenitors by C/EBPα acting at the +56 kb Irf8 enhancer. As progenitors transition to the common dendritic cell progenitor (CDP), the E-protein activity at the +41 kb Irf8 enhancer further augments the level of IRF8 expression. This progression is followed by a critical "enhancer switch" network, in which NFIL3 induced in the CDP suppresses ZEB2, causing de-repression of both ID2 and BATF3. This step terminates the +41 kb enhancer's activity while simultaneously engaging the +32 kb enhancer, where newly induced BATF3 forms a stable auto-regulatory loop with IRF8 and JUN to lock in the cDC1 fate. A notable feature of the +32 kb Irf8 enhancer is its low-affinity elements that purposely detune factor binding, called suboptimization, a property that is critical for the divergence of the cDC1 and cDC2 progenitors. The development of the cDC1 can also be abrogated in settings that disturb the normal balance of Zeb2 repression by NFIL3 and activation by C/EBP factors. Tumors producing IL-6 systemically can elevate C/EBPβ in CDPs to a point where NFIL3 fails to induce cDC1 specification. Finally, studies of compound enhancer deletions reveal that this cascade is governed by a strictly cis-dependent mechanism: the function of each subsequent enhancer is contingent on the successful prior activation of the preceding enhancer on the same chromosome. This sequential, cis-regulated activation appears to be the core mechanism for progressively tuning chromatin accessibility, ensuring robust lineage commitment. While its molecular basis is obscure, this dependency offers a new model for understanding genomic regulation in development.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.

Titre Crossref
The Making of a <scp>cDC1</scp> : Precision Programming of Progenitor Potential
Date Crossref
27/11/2025
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Immunotherapy and Immune ResponsesGenomics and Chromatin DynamicsHER2/EGFR in Cancer Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.